Tandem Diabetes Care (TNDM)
(Delayed Data from NSDQ)
$15.40 USD
-0.18 (-1.16%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $15.39 -0.01 (-0.06%) 7:58 PM ET
2-Buy of 5 2
C Value B Growth F Momentum C VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
TNDM 15.40 -0.18(-1.16%)
Will TNDM be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for TNDM based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for TNDM
Will Stereotaxis Inc. (STXS) Report Negative Earnings Next Week? What You Should Know
Tandem Diabetes Care, Inc. (TNDM) Expected to Beat Earnings Estimates: Should You Buy?
TNDM: What are Zacks experts saying now?
Zacks Private Portfolio Services
Down 27.0% in 4 Weeks, Here's Why You Should You Buy the Dip in Tandem Diabetes Care (TNDM)
TNDM Stock Gains on t:slim X2's Compatibility With FreeStyle Libre 3 +
Tandem Diabetes Care (TNDM) Up 6.5% Since Last Earnings Report: Can It Continue?
Other News for TNDM
Tandem Diabetes Care Announces Upcoming Conference Participation | TNDM Stock News
Tandem Diabetes Care Inc (TNDM) Shares Down 3.56% on Jul 15
Tandem Diabetes (TNDM) Price Target Adjusted by Leerink | TNDM Stock News
Tandem Diabetes price target lowered by $10 at Leerink, here's why
Tandem Diabetes Care Inc (TNDM) Shares Down 3.49% on Jul 11